David Gerber, MD
David E. Gerber, M.D. is a Professor of Internal Medicine and Clinical Sciences at UT Southwestern Medical Center. He received his medical degree from Cornell University Medical College and completed a residency in Internal Medicine at UT Southwestern Medical Center. He completed a fellowship in medical oncology at Johns Hopkins University School of Medicine. He joined the UT Southwestern faculty in 2007.
Dr. Gerber’s research in lung cancer has generated over 120 peer-reviewed publications. He has also written two books and more than a dozen book chapters on the topic. He has received research grants from the American Cancer Society, the American Society of Clinical Oncology, the Cancer Prevention and Research Institute of Texas, the Department of Defense, and the National Cancer Institute.
Within the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern, Dr. Gerber serves as Associate Director for Clinical Research and as Co-Leader of the Experimental Therapeutics Scientific Program. He is an active member of the Eastern Cooperative Oncology Group Thoracic Committee. He also served on the editorial board of the Journal of Clinical Oncology, as an associate scientific advisor for Science Translational Medicine, and as a grant reviewer for the Department of Defense, the American Cancer Society, and the Conquer Cancer Foundation of the American Society of Clinical Oncology.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:KaryopharmDate added:Date updated:08/22/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:BerGenBioDate added:Date updated:08/22/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AstraZenecaDate added:Date updated:08/22/2024
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:SagimetDate added:Date updated:08/22/2024
-
Attribution:SelfType of financial relationship:StockIneligible company:GileadDate added:Date updated:08/22/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Catalyst TherapeuticsDate added:Date updated:08/22/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:JanssenDate added:Date updated:08/22/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:SanofiDate added:01/03/2022Date updated:08/22/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:RegeneronDate added:01/03/2022Date updated:08/22/2024
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.